Introduction CanSino Biologics is a company that specializes in the research, production, and marketing of vaccines. Their product line includes shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was established in 2009 by a group of individuals including Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu, and Hui Hua Mao, and is based in Tianjin, China. |
Disease Domain | Count |
---|---|
Infectious Diseases | 21 |
Nervous System Diseases | 6 |
Top 5 Drug Type | Count |
---|---|
Prophylactic vaccine | 15 |
Vaccine | 4 |
Recombinant vector vaccine | 4 |
Conjugated vaccine | 3 |
mRNA vaccine | 2 |
Target |
Mechanism SARS-CoV-2 antigen inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date03 Dec 2023 |
Target |
Mechanism SARS-CoV-2 antigen inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date04 Sep 2022 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date27 Dec 2021 |
Start Date12 Jun 2024 |
Sponsor / Collaborator |
Start Date20 Mar 2024 |
Sponsor / Collaborator |
Start Date20 Mar 2024 |
Sponsor / Collaborator |